Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cardona

Showing results (171-180 of 333) with videos related to

Pageof 34
Sort By:
ESMO Open|November 16, 2016
Cancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015Christian Rolfo, Christian Caglevic, Denisse Bretel, et al.
Nutrition and Cancer|July 27, 2024
Sarcopenia as a Predictive Factor for Carboplatin Toxicity in Patients with Advanced Non-Small Cell Lung CancerJenny G Turcott, Sayako M Miyagui, Salvador Gutiérrez Torres, et al.
Journal of Thoracic Disease|June 1, 2018
Characteristics of progression to tyrosine kinase inhibitors predict overall survival in patients with advanced non-small cell lung cancer harboring an <i>EGFR</i> mutationFeliciano Barrón, Andrés F Cardona, Luis Corrales, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Metformin Enhances TKI-Afatinib Cytotoxic Effect, Causing Downregulation of Glycolysis, Epithelial-Mesenchymal Transition, and EGFR-Signaling Pathway Activation in Lung Cancer CellsPedro Barrios-Bernal, Norma Hernandez-Pedro, Mario Orozco-Morales, et al.
Journal of Alzheimer'S Disease : JAD|April 5, 2021
Short-Term Memory Binding Distinguishing Amnestic Mild Cognitive Impairment from Healthy Aging: A Machine Learning StudyJuan F Martínez-Florez, Juan D Osorio, Judith C Cediel, et al.
Critical Reviews in Oncology/Hematology|July 8, 2024
Facing an un-met need in lung cancer screening: The never smokersOscar Arrieta, Marisol Arroyo-Hernández, Pamela Denisse Soberanis-Piña, et al.
Frontiers in Oncology|October 29, 2020
Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With RadiotherapyFeliciano Barrón, Roberto Sánchez, Marisol Arroyo-Hernández, et al.
Frontiers in Oncology|February 23, 2026
Correction: Risk of developing checkpoint immune pneumonitis and its effect on overall survival in non-small cell lung cancer patients previously treated with radiotherapyFeliciano Barrón, Roberto Sánchez, Marisol Arroyo-Hernández, et al.
Metabolism: Clinical and Experimental|March 26, 2002
Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general populationF J Tinahones, J M Gómez-Zumaquero, G Rojo-Martínez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 13, 2020
Atypical Skin Manifestations During Immune Checkpoint Blockage in Coronavirus Disease 2019-Infected Patients With Lung CancerChristian Rolfo, Andrés F Cardona, Alejandro Ruiz-Patiño, et al.
Pageof 34

Showing results (171-180 of 333) with videos related to

Sort By:
Pageof 34
ESMO Open|November 16, 2016
Cancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015Christian Rolfo, Christian Caglevic, Denisse Bretel, et al.
Nutrition and Cancer|July 27, 2024
Sarcopenia as a Predictive Factor for Carboplatin Toxicity in Patients with Advanced Non-Small Cell Lung CancerJenny G Turcott, Sayako M Miyagui, Salvador Gutiérrez Torres, et al.
Journal of Thoracic Disease|June 1, 2018
Characteristics of progression to tyrosine kinase inhibitors predict overall survival in patients with advanced non-small cell lung cancer harboring an <i>EGFR</i> mutationFeliciano Barrón, Andrés F Cardona, Luis Corrales, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Metformin Enhances TKI-Afatinib Cytotoxic Effect, Causing Downregulation of Glycolysis, Epithelial-Mesenchymal Transition, and EGFR-Signaling Pathway Activation in Lung Cancer CellsPedro Barrios-Bernal, Norma Hernandez-Pedro, Mario Orozco-Morales, et al.
Journal of Alzheimer'S Disease : JAD|April 5, 2021
Short-Term Memory Binding Distinguishing Amnestic Mild Cognitive Impairment from Healthy Aging: A Machine Learning StudyJuan F Martínez-Florez, Juan D Osorio, Judith C Cediel, et al.
Critical Reviews in Oncology/Hematology|July 8, 2024
Facing an un-met need in lung cancer screening: The never smokersOscar Arrieta, Marisol Arroyo-Hernández, Pamela Denisse Soberanis-Piña, et al.
Frontiers in Oncology|October 29, 2020
Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With RadiotherapyFeliciano Barrón, Roberto Sánchez, Marisol Arroyo-Hernández, et al.
Frontiers in Oncology|February 23, 2026
Correction: Risk of developing checkpoint immune pneumonitis and its effect on overall survival in non-small cell lung cancer patients previously treated with radiotherapyFeliciano Barrón, Roberto Sánchez, Marisol Arroyo-Hernández, et al.
Metabolism: Clinical and Experimental|March 26, 2002
Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general populationF J Tinahones, J M Gómez-Zumaquero, G Rojo-Martínez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 13, 2020
Atypical Skin Manifestations During Immune Checkpoint Blockage in Coronavirus Disease 2019-Infected Patients With Lung CancerChristian Rolfo, Andrés F Cardona, Alejandro Ruiz-Patiño, et al.
Pageof 34